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Abstract
Background: As nuclear mediators of wnt/β-catenin signaling, Lef/Tcf transcription factors play
important roles in development and disease. Although it is well established, that the four vertebrate
Lef/Tcfs have unique functional properties, most studies unite Lef-1, Tcf-1, Tcf-3 and Tcf-4 and
reduce their function to uniformly transduce wnt/β-catenin signaling for activating wnt target genes.
In order to discriminate target genes regulated by XTcf-3 from those regulated by XTcf-4 or Lef/
Tcfs in general, we performed a subtractive screen, using neuralized Xenopus animal cap explants.
Results: We identified cold-inducible RNA binding protein (CIRP) as novel XTcf-3 specific target
gene. Furthermore, we show that knockdown of XTcf-3 by injection of an antisense morpholino
oligonucleotide results in a general broadening of the anterior neural tissue. Depletion of XCIRP
by antisense morpholino oligonucleotide injection leads to a reduced stability of mRNA and an
enlargement of the anterior neural plate similar to the depletion of XTcf-3.
Conclusion: Distinct steps in neural development are differentially regulated by individual Lef/
Tcfs. For proper development of the anterior brain XTcf-3 and the Tcf-subtype specific target
XCIRP appear indispensable. Thus, regulation of anterior neural development, at least in part,
depends on mRNA stabilization by the novel XTcf-3 target gene XCIRP.
Background
The most prominent nuclear transducer of wnt/β-catenin
signaling in the nucleus belong to the Lef/Tcf family of
sequence specific HMG-box transcription factors. Higher
vertebrates express four distinct members of this family,
Tcf-1 (or Tcf-7), Tcf-3, Tcf-4 (or Tcf-7 like 2) and Lef-1
[1,2]. In Xenopus, XTcf-1, XTcf-3 and XTcf-4 are maternally
provided, while the expression of XLef-1 starts only after
mid-blastula transition [3]. The expression of XTcf-1,
XTcf-3 and XLef-1 is widespread and overlapping in many
tissues, with highest levels in the head region including
brain, head mesoderm and branchial arches [3,4]. Zygotic
expression of XTcf-4 is restricted in neurula and tailbud
stages to the anterior midbrain [5] and in tadpoles to the
entire midbrain [6].
A partial functional redundancy of Lef/Tcf family mem-
bers has been shown in mice, where the Tcf-1/Lef-1 and
Tcf-1/Tcf-4 double knock-out mice revealed more than
additive effects compared to the corresponding single
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knock-out mice [7,8]. In Xenopus, however, the individual
Lef/Tcfs appear to have more non-redundant roles.
Although XTcf-1, XTcf-3 and XTcf-4 are maternally pro-
vided, it has been shown by rescue experiments of Lef/Tcf
depleted embryos that XTcf-1 mediated target gene activa-
tion in partial redundancy with XTcf-4, and XTcf-3 medi-
ated target gene repression are required for establishing of
the dorsal embryonic axis [9] and mesoderm patterning
[10]. Zygotic XTcf-4 has been shown to regulate midbrain
development [6]. XLef-1 is necessary for mesoderm pat-
terning [11]. These non-redundant roles of Lef/Tcfs during
early Xenopus development implicate that the individual
transcription factors regulate a different subset of target
genes.
It seems most likely that Lef/Tcfs are general regulators of
brain development because their expression overlaps in
the developing brain and posteriorization of the develop-
ing CNS is regulated by wnt/β-catenin signaling [12].
Thereby, they seem not to play a role as inducing factors,
driving the cell fate towards anterior neural development,
because they can not induce the expression of neural
marker genes in Xenopus  animal cap explants. Instead,
they rather appear to be involved in the stabilizing and
transforming step in the model of Stern [13]. However,
dorsal injection of a dominant negative Tcf-3 construct
resulted in a repression of Bmp4 and subsequently in a
downregulation of the pan-neural marker gene nrp1 [14].
This is discussed as β-catenin independent target gene
activation by a physical interaction between XTcf-3 and
Frodo/Dapper [15].
In order to identify genes specifically regulated by XTcf-3,
we subtracted the transcriptome of neuralized animal
caps of Tcf-4 morpholino injected embryos from those of
Tcf-3 morpholino injected ones and identified among
others  Xenopus  cold inducible RNA binding protein
(XCIRP) as novel XTcf-3 specific target gene. XCIRP was
originally identified in a screen for target genes activated
after retinoic acid treatment of activin treated explants
[16]. Later it was found in a screen for genes, which are
upregulated in animal caps neuralized by smad7 [17]. In
Xenopus  three XCIRP isoforms, XCIRP, XCIRP1 and
XCIRP2 have been reported. Because XCIRP and XCIRP1
mRNA is to 98% identical resulting in proteins of 99.4%
identity they are referred in here further on as XCIRP.
XCIRP protein is to 94% identical to XCIRP2, implicating
that these isoforms derive from different alleles of the
pseudotetraploid Xenopus laevis.
XCIRP is highly expressed in developing oocytes and
forms together with FRGY2 and mRNP3 the most abun-
dant group or RNA binding proteins in oocytes [18,19]. It
interacts with and is methylated by the protein-arginine
methyltransferase 1 (XPRMT1). This methylation is sup-
posed to play an essential role in regulating the subcellu-
lar localization of XCIRP [20]. XCIRP interacts with ELAV-
like RNA-binding protein (XELrA) in vitro and in vivo and
inhibits deadenylation of synthetic AU rich elements [19].
Immunoprecipitation followed by RT-PCR revealed that
many different mRNAs including cyclin B1, CAF1 p150
(Chromatin assembly factor 1 p150 subunit) Nek2B,
Cytochrome C oxidase peptide VIb and bystin bind to
XCIRP protein in Xenopus oocytes [19]. In a similar assay,
Peng et al. [21] identified α- and β-catenin as well as C-
and E-cadherin mRNA bound to XCIRP protein. Binding
of XCIRP to the above mentioned mRNAs appears to
increase their stability [21]. Whether binding and stabili-
zation of mRNA holds true only for a small subset of
mRNA or if mRNA in general is stabilized by XCIRP
remains elusive.
Although almost ubiquitously expressed at high levels
during gastrulation [16], first effects of XCIRP knockdown
by antisense morpholino injection were not seen before
stage 22, where more than half of the embryos died [22].
More specific effects of the XCIRP morpholino were
observed only after targeting the injection to the C3 blas-
tomere in 32 cell stage embryos. This resulted in malfor-
mation of the pronephros [22].
Here we show by antisense morpholino oligonucleotide
injection followed by in situ hybridization that the expres-
sion of XCIRP depends on XTcf-3 but not on XLef-1 or
XTcf-4. The expression fields of XTcf-3 and XCIRP broadly
overlap in the neural tissue and both, the XTcf-3 specific
and the XCIRP specific anitsense morpholino oligonucle-
otide lead to a similar phenotype, a broadening of the
neuroectoderm. We provide evidence, that a general stabi-
lization of mRNA by the XTcf-3 target gene XCIRP is an
essential step in early neural development.
Results
In order to identify target genes specifically regulated by
XTcf-3 in brain development, we subtracted the transcrip-
tome of neuralized animal caps deriving from XTcf-3 mor-
pholino injected embryos from those of XTcf-4
morpholino injected embryos and amplified the remain-
ing cDNAs. Injection of 100 pg RNA encoding a dominant
negative BMP receptor was sufficient to induce the pan-
neural marker gene NCAM in animal cap tissue (Fig. 1B).
Thus, for our subtraction we used a relatively homoge-
nous and defined tissue, simply differing in the presence/
absence of XTcf-3 and XTcf-4. Genes regulated by Lef/Tcf
transcription factors in general should be eliminated dur-
ing subtraction and only XTcf-3 specific target genes
should be enriched.
Among others (additional file 1), we found as putative
XTcf-3 specific target genes most abundant, high mobilityBMC Developmental Biology 2008, 8:77 http://www.biomedcentral.com/1471-213X/8/77
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Figure 1
XCIRP is regulated by XTcf-3, but not by XTcf-4. (A) RT-PCR on sibling embryos (emb), animal cap explants of naive 
animal caps (cont), neuralized animal caps (tBr, cont) and neuralized animal caps coinjected with truncated BMP receptor (tBr) 
and the indicated morpholino (Tcf3Mo: XTcf-3 specific antisense morpholino oligonucleotide, Tcf4Mo: XTcf-4 specific anti-
sense morpholino oligonucleotide) revealed that following XTcf-3 depletion, the expression of XCIRP and XCIRP2, as well as 
the cement gland specific marker gene XAG is robustly downregulated. The expression of HMGN1, HMGN2 and HMGX is 
not regulated in a Tcf-subtype specific manner. ODC shows the amplification of the house keeping gene ornithine decarboxylase, 
-RT is the control amplification of not reverse transcribed RNA. (B) RT-PCR on sibling embryos (emb), animal cap explants of 
naive animal caps (cont) and neuralized animal caps (tBr) demonstrate that the pan-neural marker gene NCAM is induced by 
injection of 100 pg mRNA encoding for truncated BMP receptor (tBr). H4 shows the amplification of the house keeping gene 
histone 4, -RT is the control amplification of not reverse transcribed RNA. (C) Sequence alignment of the Lef/Tcf specific anti-
sense morpholino oligonucleotides together with the corresponding mRNAs, start codons of the Lef/Tcfs are indicated in bold. 
Tcf4Mo: XTcf-4 specific antisense morpholino oligonucleotides, Tcf3Mo: XTcf-3 specific antisense morpholino oligonucle-
otides, LefMo1 and LefMo2: XLef-1 specific antisense morpholino oligonucleotidess. (D-F) Specificity of the Lef/Tcf mor-
pholinos towards their target mRNA, (D) reduction of in vitro translated S-35 labelled XLef-1 protein in the presence of the 
indicated morpholinos, The asterisk marks an unspecific band. (E) reduction of injected C-terminally myc-tagged XTcf-4 by 
coinjection of ten picomoles Tcf4Mo, but not two picomoles Tcf3Mo. The asterisks indicate unspecific staining. Gemin staining 
was used as loading control. (F) reduction of injected C-terminally myc-tagged XTcf-3 by coinjection of two picomoles Tcf3Mo, 
but not ten picomoles Tcf4Mo. Gemin staining was used as loading control.
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group nucleosomal binding protein 1 and 2 (HMGN1
and 2), HMGB3, Xenopus  anterior gradient (XAG) and
cold inducible RNA binding protein (XCIRP and
XCIRP2).
To confirm the target genes, we analyzed via  RT-PCR
whether these genes are down regulated in neuralized ani-
mal caps following XTcf-3 depletion (Fig. 1A). Indeed, the
expression of XCIRP, XCIRP2 and XAG depended on the
presence of XTcf-3, but not on the presence of XTcf-4.
Other candidate genes, including the HMG-box proteins
HMGN1, HMGN2 and HMGX, however, were not regu-
lated in a Tcf-subtype specific manner. The down regula-
tion of XAG and XCIRP following XTcf-3 depletion, goes
ahead with a reduction of the anterior neural marker gene
XANF, indicating that the presence XTcf-3 in general is
indispensable for anterior neural development. This is
further sustained by the finding, that also the pan-neural
marker gene NCAM is much stronger downregulated by
XTcf-3 depletion than by XTcf-4 depletion (Fig. 2A).
We confirmed the specificity of the morpholinos towards
their target-mRNA. Sequence alignment revealed that the
subtype specific morpholino oligonucleotides although
perfectly matching their target mRNA contain at least 7
mismatches to the mRNA of the other family members
(Fig. 1C). In immunoblots we showed, that all three mor-
pholino oligonucleotides suppress translation of their tar-
get mRNAs (Fig. 1D, E, F) and that the XTcf-3 specific
morpholino has only minor effects on XTcf-4 translation
(Fig. 1E) and vice versa (Fig. 1F). Consistently, also the
RNA-levels of XTcf-3 and XTcf-4 in neuralized animal caps
remained unchanged following morpholino injection
(Fig. 2A) and the main XTcf-4 isoform in neuralized ani-
mal caps is XTcf-4B, regardless whether a morpholino was
injected or not (Fig. 2C).
However, analysis of XLef-1 and XTcf-1 in XTcf-3- and 4
depleted neuralized animal caps (Fig. 2A) and in caps
overexpressing Lef/Tcfs (Fig. 2B) revealed a complex cross-
regulation of these transcription factors. Expression of
XTcf-1 and XLef-1 depended on the presence of XTcf-3
and XTcf-4 and overexpression of XTcf-3 induced both,
XTcf-1 and XLef-1 (Fig. 2B). XTcf-4 overexpression, how-
ever, induced XLef-1 but repressed XTcf-1 (Fig. 2B). The
complexity of this cross-regulation is further sustained by
the finding that XTcf-3 expression is specifically upregu-
lated following XLef-1 and XTcf-1, but not XTcf-4 mRNA
injection, regardless whether an activating (XTcf-4C) or
repressing (XTcf-4A) isoform was used. Regulation of the
direct wnt target gene XTcf-4 by Lef/Tcfs is seen by the
induction of XTcf-4 following XTcf-3, XTcf-1 and XLef-1
overexpression (Fig. 2B).
Thus, a complex cross-regulation of Lef/Tcfs seems to
complicate the analysis.
If the potential target genes identified in neuralized ani-
mal caps are endogenously regulated by XTcf-3, they
should be co-expressed with XTcf-3. Indeed, in situ hybrid-
ization revealed that HMGN1 and 2, HMGX and XCIRP
are broadly co-expressed with XTcf-3 at late neurula stages
in the neural plate (Fig. 3A). While XTcf-3, HMGN1 and 2
and XCIRP demarcate the anterior border of the neural
plate, highest expression of HMGX is found in the pro-
spective midbrain and hindbrain, posterior to the XTcf-4
expression field, but still overlapping with XTcf-3. The co-
expression persists throughout development. In tailbud
stages, XTcf-3, HMGN1 and 2, HMGX and XCIRP are
prominently expressed in the head, including brain, eye,
otic vesicles and branchial arches of the neural crest. A
closer look-up reveals a partial co-localisation of XCIRP
and XTcf-3 at gastrula stages, where both genes are
expressed in the involuting mesoderm and at neurula
stages, where they are co-localized in the neural plate (Fig.
3B). Thus, XCIRP is expressed throughout early embryo-
genesis with a broad overlap to XTcf-3 (see also additional
file 2).
Unilateral depletion of XTcf-3 results only in a minor mis-
regulation of HMG-box gene expression. While the
expression of HMGN1 was not at all altered by the XTcf-3
morpholino, HMGN2 and HMGX appear expanded at the
injected side (additional file 3). The expression of XCIRP
in the neural plate, however, clearly depends on the pres-
ence of XTcf-3. Following XTcf-3 morpholino injection
the expression of XCIRP was robustly reduced at the
injected side (Fig. 3C). This regulation was Tcf-subtype
specific since depletion of XTcf-4 and XLef-1 did not alter
XCIRP expression (Fig. 4A). Co-injection of XTcf-3 mRNA
together with the XTcf-3 morpholino restored XCIRP
expression in a dose dependent manner (Fig. 4B, C), indi-
cating that XCIRP indeed is regulated by XTcf-3. Accord-
ingly, co-injection of XTcf-1 and XTcf-4A or -C did not
restore XCIRP expression while surprisingly, XLef-1 and to
a minor extent β-catenin did (Fig. 4B, D). Thus, XCIRP is
a Tcf-subtype specific target gene. Its zygotic expression in
the neural plate strictly depends on the presence of XTcf-3
and not on XLef-1 and XTcf-4. However, overexpressed
XLef-1 can replace endogenous XTcf-3.
Apart from the total absence of XCIRP staining at the
injected side a severe phenotype following XTcf-3 deple-
tion was an expansion of anterior neural tissue as shown
by the expression of HMGN1 and HMGX (additional file
3), and more obviously by the lateral expansion of sox2
(Fig. 5A). Again, this phenotype was specific for XTcf-3
depletion. Depletion of XLef-1 and XTcf-4 did not alter
sox2 expression. Co-injection of XTcf-3 mRNA partiallyBMC Developmental Biology 2008, 8:77 http://www.biomedcentral.com/1471-213X/8/77
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restored normal sox2 expression (Fig. 5B). Interestingly,
although co-injected XCIRP mRNA did not restore normal
sox2 expression in XTcf-3 depleted embryos (data not
shown), coinjection of XCIRP mRNA together with XTcf-
3 mRNA revealed a better rescue than coinjection of XTcf-
3 alone (Fig. 5B). Furthermore, similar to XTcf-3 deple-
tion, also downregulation of XCIRP resulted in a lateral
expansion of sox2 expression at the injected side (Fig. 5A,
B), suggesting, that XCIRP as XTcf-3 target gene is neces-
sary for proper neural development. Injection of CIRP-Mo
and XTcf3Mo resulted in a similar downregulation of
XCIRP protein (Fig. 5C). Due to the high similarity of
XCIRP and XCIRP2, we assume that the morpholino sup-
presses the translation of both isoforms. Indeed, the
Regulation of Lef/Tcf expression by Lef/Tcfs in neuralized animal caps Figure 2
Regulation of Lef/Tcf expression by Lef/Tcfs in neuralized animal caps. (A) RT-PCR on sibling embryos (emb), animal 
cap explants of naive animal caps (cont), neuralized animal caps (tBr) and neuralized animal caps coinjected with truncated BMP 
receptor (tBr) and the indicated morpholino (Tcf3Mo: XTcf-3 specific antisense morpholino oligonucleotide, Tcf4Mo: XTcf-4 
specific antisense morpholino oligonucleotide) revealed that the expression of XLef-1 and XTcf-1 (but not of XTcf-3 and XTcf-
4) depends on the presence of XTcf-3 and XTcf-4. NCAM is the amplification of the pan-neural marker gene neural cell adhe-
sion molecule, H4 the amplification of the house keeping gene histone 4, -RT the control amplification without reverse transcrip-
tion. (B) Co-injection of 500 pg Lef/Tcf mRNA together with 100 pg tBr indicated complex cross-regulation of Lef/Tcf 
transcription factors in neuralized animal caps. NCAM is the amplification of the pan-neural marker gene neural cell adhesion 
molecule, H4 the amplification of the house keeping gene histone 4, -RT the control amplification without reverse transcription. 
(C) The pattern of XTcf-4 isoforms remained unchanged following XTcf-3 and XTcf-4 knockdown. Amplicons were digested 
with isoform-specific restriction enzymes (1: XbaI, 2: RsaI, 3: XbaI + RsaI) and analysed according to [27].
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Figure 3
Coexpression of XTcf-3 and putative XTcf-3 target genes. In situ hybridization reveals synexpression of XTcf-3, 
HMGN1, HMGN2, HMGX and XCIRP throughout early embryonic development. (A) At neurula stages all five genes are co-
expressed and demarcate the anterior border of the neural plate (arrowhead). The main expression of HMGX is found in 
more posterior neural tissue (arrow) adjacent to the XTcf-4 expression field. The coexpression persists during early embryo-
genesis and is found in tailbud stages in head structures, including brain, eye, otic vesicle and branchial arches. (B) During gas-
trulation, XTcf-3 and XCIRP are co-expressed at the dorsal blastopore lip (arrowhead upper panel). The higher magnification 
reveals that both genes are expressed in the involuting mesoderm (anterior most mesoderm is indicated by a red arrowhead). 
In the endoderm (black arrowhead) underlying the involuting mesoderm, neither XTcf-3 nor XCIRP are expressed. While 
XTcf-3 is predominantly localized in the mesoderm (black arrow), the highest expression of XCIRP is found in the ectoderm 
(red arrow). But still substantial amounts of XCIRP RNA are detected in the mesoderm (black arrow). In anterior transversal 
sections of stage 18 embryos (lower panel) mRNA of both, XTcf-3 and XCIRP, is located in the neuroectoderm (arrowhead). 
While XTcf-3 is additionally found in the paraxial mesoderm (arrow), the most prominent XCIRP staining apart from the neu-
ral plate is located in the epidermis. (C) A higher magnification of transversal sections shows that following XTcf-3 morpholino 
injection (Tcf3Mo) XCIRP is strongly reduced in the neural plate (arrow) at the injected side (marked with an asterisk).
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XCIRP is a Tcf-subtype specific target gene Figure 4
XCIRP is a Tcf-subtype specific target gene. (A) Anterior view of in situ hybridization reveals that depletion of XTcf-3 by 
morpholino injection (Tcf3Mo), but not depletion of XTcf-4 (Tcf4Mo) or XLef-1 (LefMo1,2) results in an absence of XCIRP 
staining at the injected side (asterisk). (B) XCIRP expression in Tcf3Mo injected embryos can be restored by co-injection of 
XTcf-3 and XLef-1 mRNA. The asterisks mark the injected side. (C, D) The rescue of XCIRP expression by XTcf-3 is dose 
dependent and Tcf-subtype specific. In (C): the indicated amount of N-terminal myc tagged XTcf-3mRNA was co-injected with 
two picomoles of Tcf3Mo. In (D): 1000 pg of the indicated Lef/Tcf mRNA or 300 pg β-catenin mRNA were coinjected with 
two picomoles of Tcf3Mo. Given is the percentage of embryos showing reduced or absent XCIRP expression at the injected 
side. n: number of analyzed embryos.
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Figure 5
Depletion of XTcf-3 and XCIRP results in a lateral expansion of sox2. (A) In situ hybridization revealed that both, 
XTcf-3 and XCIRP are required for proper neural development. The expression of sox2 was laterally expanded (arrow) at the 
injected side (asterisk). Two picomoles Tcf3Mo, eight picomoles Tcf4Mo or two picomoles CIRP-Mo or two picomoles 
LefMo1 + two picomoles LefMo2 were coinjected with 4 pg dextrane (to trace the injected side) and 1000 pg XTcf-3 mRNA 
or 200 pg XCIRP DNA into one blastomere of 2-cell stage embryos. (B) Quantification of the lateral expansion. 71,2% of the 
Tcf3Mo, 51,5% Tcf3Mo+XTcf-3, 36% Tcf3Mo+XTcf-3+XCIRP, 53% of the CIRP-Mo and 30% of the CIRP-Mo+CIRP and 0% of 
the Tcf4Mo and LefMo, injected embryos showed a lateral expansion of sox2. n: number of analyzed embryos. (C) The align-
ment of the XCIRP antisense morpholino oligonucleotide (CIRP-Mo) with XCIRP and XCIRP2 indicates that it is supposed to 
block both isoforms. The Western Blot demonstrates that the amount of endogenous XCIRP protein is reduced following 
CIRP-Mo injection. The reduction of XCIRP protein by blocking XTcf-3 translation (Tcf3Mo) can be restored by co-injection 
of XTcf-3 mRNA (Tcf3Mo + XTcf-3). Two picomoles CIRP-Mo, two picomoles Tcf3Mo and two picomoles Tcf3Mo + 1000 pg 
XTcf-3 mRNA were injected into both blastomeres of 2-cell stage embryos. RIPA lysates corresponding two 1/3 embryo 
where separated on a 15% SDS page and either stained with coomassie (CBB) as loading control or transferred to nitrocellu-
lose and stained with anti-CIRP polyclonal antiserum (α-CIRP).(D) The anti-CIRP polyclonal antiserum (α-CIRP), originally 
directed against XCIRP2 [18] recognizes both, endogenous XCIRP/XCIRP2 (blue arrow) and overexpressed XCIRP (black 
arrow). Staining with the anti-myc antibody shows the overexpressed myc-tagged XCIRP (black arrow) and some faster 
migrating proteins, which correspond most likely to degradation products.
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XCIRP-myc
Control
XCIRP-myc
D
Tcf3Mo
** *
Tcf4Mo CIRP-Mo
Tcf3Mo
+XTcf-3
CIRP-Mo
+XCIRP
LefMo1,2
** *
controlBMC Developmental Biology 2008, 8:77 http://www.biomedcentral.com/1471-213X/8/77
Page 9 of 14
(page number not for citation purposes)
XCIRP specific antibody directed against XCIRP2 [18] also
recognized overexpressed XCIRP (Fig. 5D),
The lateral expansion of anterior neural tissue following
XCIRP or XTcf-3 depletion could be due to misregulation
of morphogenetic movements during neural tube forma-
tion, or to alteration in cell fate determination. In whole
embryos, we never observed induction or repression of
pan-neural, -epidermal or -mesodermal marker genes fol-
lowing morpholino-injections (data not shown), suggest-
ing that the general cell fate decisions are not altered by
the morpholinos. Instead, meis3 at the posterior mid-
brain and hindbrain was expanded and eya1, demarcating
the placodal region was shifted laterally at the injected
side (additional file 4), most likely as consequence of the
lateral expansion of anterior neural tissue. To determine
whether convergent extension movements are misregu-
lated following morpholino injection, we analyzed the
elongation of Keller open face explants [23] and found
that depletion of XCIRP has no effect on these movements
(Fig. 6A).
The molecular mechanism of XCIRP, regulating proper
development of neural tissue is most likely due to its func-
tion as RNA-binding protein. XCIRP is known to stabilize
a large number of different mRNAs, including N-cadherin,
E-cadherin, β-catenin, cyclin B1, Nek2B, Cytochrome C
oxidase peptide VIb and bystin [19,21]. In order to deter-
mine, whether a small subset of mRNA or mRNA in gen-
eral is stabilized by XCIRP, we compared the mRNA/RNA
relation of control embryos with XCIRP depleted ones.
Indeed, following XCIRP morpholino injection, the
mRNA pool was reduced by 10–15% (Fig. 6B, C) indicat-
ing that XCIRP as one of the most abundant RNA binding
proteins in early Xenopus development is involved in sta-
bilizing many different mRNA populations.
Thus, we identified in here the RNA binding protein
XCIRP as novel Tcf-subtype specific target gene, which by
stabilization of a large pool of mRNAs allows proper ante-
rior neural development.
Discussion
In a subtractive screen specific for Tcf-subtype specific tar-
get genes one of the most frequently candidate genes, cold
inducible RNA binding protein XCIRP, was found to be reg-
ulated by XTcf-3, but not by other Lef/Tcfs. Cement gland
specific marker genes, although not co-localized with
XTcf-3 in the embryo, have been shown to be repressed by
injection of dominant negative XTcf-3 [24]. Consistently,
among our XTcf-3 target genes we identified the cement
gland specific marker genes XAG and XAG2. Other candi-
date genes enriched in the subtractive screen are supposed
to be expressed rather in ectodermal than in neuroecto-
dermal tissue (α-tubulin, cytokeratine type II, cytokera-
tine 81 [25,26] or their expression did not strictly depend
on the presence of XTcf-3 (HMGN1, HMGN2, HMGX).
Interestingly, we did not enrich any "classical" wnt target
gene in our screen, which might be explained by their par-
tial redundant roles in transducing wnt/β-catenin signal-
ing or by cross-regulation of their expression. Based on
our results, one could suspect, that general wnt/β-catenin
target genes are not enriched in the subtractive screen,
because both, the XTcf-3 depleted and the XTcf-4 depleted
pool also contained less XTcf-1 and XLef-1. Thus, only
subtype-specific target genes will be detected, while gen-
eral wnt/β-catenin target genes are underrepresented.
Although differential activation of wnt/β-catenin target
gene promoters by individual Lef/Tcf family members
have been reported over the last years [9,24,27-29], most
studies dealing with wnt/β-catenin signaling still unite
Lef-1, Tcf-1, Tcf-3 and Tcf-4 as Lef/Tcfs and implicate that
they are exchangeable. Thus far, non-sequence specific
DNA binding and recruitment of p300 by the Tcfs E-tail
[30,31] and epigenetic modifications of wnt target gene
promoters [29] provide the best explanations for subtype
specific target gene regulation. Recently, it has been
shown in Drosophila, that pangolin/armadillo also pro-
motes target gene repression by binding to DNA
sequences different to the "classical" Lef/Tcf binding side
[32]. Whether a similar mechanism also regulates Tcf-sub-
type specificity in vertebrates remains elusive.
With XCIRP, we describe for the first time a novel Lef/Tcf
target gene, which is endogenously regulated in a Tcf-sub-
type specific manner. XTcf-3 but not XTcf-4 and XLef-1 is
required for the XCIRP expression in the neural plate.
Furthermore, XCIRP expression can be restored by XTcf-3
but not by XTcf-1 and XTcf-4, indicating that Lef/Tcfs are
not exchangeable. However, the fact that XLef-1 can
restore XCIRP expression in a similar extent as XTcf-3
revealed some redundant functions of XTcf-3 and XLef-1.
This redundant function is somehow unexpected, because
we recently could show that XTcf-3 in general behaves as
a repressor and XLef-1 as an activator [27,28]. Keeping in
mind the redundant functions of murine Lef/Tcfs revealed
by loss of function studies and double knockouts in mice
[7,8] it is surprising, that we could detect such specific reg-
ulation of XCIRP expression by individual Lef/Tcfs, even
more, since it has been shown in different contexts that
the expression of Lef/Tcf transcription factors is regulated
by Lef/Tcfs (this study, 33,34,35). However, this complex
cross-regulation provides an explanation for the unex-
pected reconstitution of XCIRP expression following XLef-
1 injection in XTcf-3 depleted embryos: Because overex-
pression of XLef-1 upregulates XTcf-3, the recovery of
XCIRP might be a secondary effect and still due to a sub-
type-specific regulation by XTcf-3. ChIP with XTcf-subtypeBMC Developmental Biology 2008, 8:77 http://www.biomedcentral.com/1471-213X/8/77
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Depletion of XCIRP causes reduction of mRNA Figure 6
Depletion of XCIRP causes reduction of mRNA. (A) XCIRP is not necessary for convergent extension movements. Sim-
ilar to dorsal animal zone explants of control embryos, more than 60 percent of the explants of CIRP-Mo injected embryos 
elongate. 0 and 1 indicate non-elongated explants, 2 indicate elongated and restricted explants and 2X elongated, but not con-
stricted explants according to Schambony and Wedlich [27]. (B, C) Depletion of XCIRP results in a reduction of mRNA. Total 
RNA of stage 16 embryos was reverse transcribed either with oligo dT primer (mRNA) or random hexamer primer (total 
RNA) in the presence of 60 μCi P32 α-dCTP. (B) Shows an autoradiograph of a representative gel with a smear of labeled 
cDNA, the free radioactive nucleotides and the background. (C) The signals were quantified by setting the relation of mRNA/
total RNA for the control as 1. Shown is the average and standard error for 3 independent experiments.
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specific antibodies will help to define whether endog-
enous XCIRP, indeed, is directly regulated by XTcf-3 and
not by XLef-1.
Lef/Tcf transcription factors as transducer of the wnt/β-
catenin signaling pathway have been reported to regulate
anterior posterior patterning of the CNS. While activation
of wnt/β-catenin signaling in general posteriorizes the
CNS [12], wnt-2b/XTcf-4 regulates the development of
the midbrain [6]. Here we show that XTcf-3 is required for
proper development of the neural plate. Depletion of
XTcf-3 results in a lateral expansion of the pan-neural
marker gene sox2, the midbrain specific marker gene
Meis3 and to a shift of the placodal marker gene eya1. A
similar broadening of the anterior neural plate was
observed following injection of dominant negative XTcf-3
[24]. Thus, inhibition of wnt/β-catenin signaling is
required for neural induction and injection of dn XTcf-3 is
thought to mimick the effect of endogenous wnt inhibi-
tors. In contrast to the dominant negative XTcf-3 in Heeg-
Truesdells study [24], the XTcf-3 morpholino did not
result in neural induction. This might be due to the fact
that the N-terminal deletion mutant competes with all
Lef/Tcfs, thus is not strictly specific for XTcf-3.
A similar broadening of the neuroectoderm was also
observed following depletion of the transcription factors
zic-1 [36] and six1 [37]. In contrast to the depletion of zic-
1 and six1, the broadening of the anterior neural tissue
following depletion of XTcf-3 did not go ahead with a
reduction of placodal marker genes, thus, did not affect
the organization of the neural plate border. Although
wnt/β-catenin signaling is involved in the induction of
cranial placodes [38], the expression of the placodal
marker gene eya1 seems to be unaffected by depletion of
XTcf-3. This opens up the question, how XTcf-3 can lead
to a broadening of the neural plate without affecting the
integrity of the adjacent placodal region. We provide evi-
dence, that stabilization of a large pool of mRNAs by the
XTcf-3 target XCIRP might be an explanation.
Depletion of the XTcf-3 target gene XCIRP resulted in a
similar lateral expansion of neural tissue, indicating that
XCIRP is an important downstream component of XTcf-3
for neural development. One obvious mechanism for this
broadening would be a failure in convergent extension
movements, which might be caused by a destabilization
of the mRNA of cell adhesion molecules including C- and
E-Cadherin, β-Catenin, and α-Catenin [21]. According to
our dorsal marginal zone explants, we can exclude an
effect on convergent extension movements, because injec-
tion of the CIRP morpholino did not result in an inhibi-
tion of elongation or constriction of the explants. The
molecular mechanism of XCIRP action during early
embryonic development is most likely due to a stabiliza-
tion of mRNA. CIRP has been shown to bind to and stabi-
lize many different mRNAs, including those encoding for
cell adhesion molecules and cell proliferation regulators
[19,21]. Thus, CIRP is supposed to act as a general mRNA
binding protein, which regulates the stability of a large
pool of different mRNAs. Consistently, we can show that
the total mRNA pool is decreased following XCIRP mor-
pholino injection, indicating that apart the thus far iden-
tified XCIRP target mRNAs a big pool of additional
mRNAs is regulated by XCIRP. Thus, we conclude that the
XTcf-3 target gene XCIRP regulates the correct positioning
of the neural border by regulating the stability of many
different mRNAs. We think that deciphering the identity
of the XCIRP regulated mRNA pool will give enormous
progress in understanding the mechanisms underlying
early neural development and the positioning of the neu-
roectoderm/ectoderm border. Furthermore, the specific
effect of XCIRP depletion on neural development together
with the distinct expression domains of different RNA
binding proteins including XCIRP, SEB4 [39], nrp-1 [40]
and elav-like proteins [41] might reflect a general mecha-
nism in development: stabilization of a distinct cell fate
by regulating the stability (or translation) of a broad vari-
ety of mRNAs in a tissue specific manner.
Conclusion
In a screen for Tcf-subtype specific target genes we identi-
fied cold inducible RNA binding protein XCIRP as novel
XTcf-3 specific target gene. Both, XTcf-3 and XCIRP are
required for proper anterior neural development. We pro-
vide evidence, that RNA stabilization by the XTcf-3 spe-
cific target gene XCIRP is essential for anterior neural
development.
Methods
Plasmids, constructs, in vitro transcription
Capped mRNAs were transcribed from linearized DNA
templates using mMESSAGE mMACHINE (Ambion).
Digoxigenin labeled antisense probes for in situ hybridiza-
tion were synthesized with DIG RNA labeling kit (Roche).
Probes for in situ hybridization are described elsewhere:
sox2 [15], Tcf-4 [5], HMGN1 and HMGN2 [42], HMGX
[43], Meis3 and eya1 [44]. The open reading frame of
XCIRP was amplified using the following primers: XCIRP-
start: 5'-tcagaattcaatgtctgacgaaggaaaact-3' and XCIRPstop
5'-cttctcgagttactcgtgtgtagcatagctg-3' and sub-cloned into
pGEMT for creating labeled antisense RNA and into pCS2
for synthesizing myc tagged mRNA. cDNA corresponding
to aa 63–328 of XTcf-3 [45] was inserted into pGEMT for
creating labeled antisense RNA. The following antisense
morpholino oligonucleotides (Gene Tools, LaJolla) were
used: XTcf-3 (Tcf3Mo, MO#-Tcf7l1): 5'-cgctgttgagctgag-
gcatgatgag-3' (directed against BC077764); XTcf-4
(Tcf4Mo, MO#-tcf4): 5'-cgccattcaactgcggcatctctgc-3'
(directed against BC106476), XLef-1 LefMo1, MO#-BMC Developmental Biology 2008, 8:77 http://www.biomedcentral.com/1471-213X/8/77
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LEF1): 5'-tacggagtcgagagacctcgtccc-3' and (LefMo2, MO#-
LEF1): 5'-caagacctcggtacggagtcgagag-3' (directed against
NM_001088655 und AC151234) and XCIRP (CIRP-Mo,
MO#-CIRBP): 5'-agtacagactgcttccttttgaga-3' (directed
against XCIRP NM_00108600, XCIRP1 AF278702 and
XCIRP2 NM_001086325). The concentrations injected
are given in the figure legends and were tested to be non-
toxic.
Selective subtractive screen
Eggs from HCG treated females were fertilized by standard
methods and staged according to [46]. For animal cap
explants eight picomoles of XTcf-3 and XTcf-4 mor-
pholino where co-injected with 100 pg mRNA encoding
for a truncated version of the BMP receptor (tBr) into both
blastomeres of 2-cell stage embryos. At late blastula, ani-
mal caps where explanted and cultivated until sibling
embryos reached stage 16. The transcriptome of Tcf-3
depleted neuralized animal caps was subtracted from the
transcriptome of Tcf-4 depleted ones using the "PCR-
Select cDNA Subtraction Kit" (BD Biosciences, Heidel-
berg, Germany) according to manufacturers description.
Embryo treatment and in situ hybridization
For marker gene analysis, the indicated morpholinos
where co-injected into one blastomere of Xenopus 2-cell
stage embryos with 4 pg dextrane or 100 pg mRNA encod-
ing for myc-tagged GFP as lineage tracer. At neurula stages,
embryos were fixed in MEMFA (0.1 M MOPS pH 7.2, 2
mM EGTA, 1 mM MgSO4, 3.7% formaldehyde). For
vibratome sections, fixed embryos were embedded in 3%
agarose and sectioned using a Leica VT 1000S vibratome.
Whole-mount in situ hybridization was performed accord-
ing to previously described procedures [47]. Localization
of mRNA was visualized using anti-digoxigenin antibod-
ies conjugated to alkaline phosphatase, followed by incu-
bation with nitro blue tetrazolium (NBT) and 5-bromo 4-
chloro 3-indolyl phosphate (BCIP). Images were captured
on a Leica MZFLIII microscope using a digital camera
(Qimaging) and Improvision software (Openlab).
For analyzing convergent extension movements, dorsal
marginal zone explants were cut at blastula stages, culti-
vated until siblings reached stage 16 and analyzed accord-
ing to [23].
Immunoblotting
RIPA lysates corresponding to one half embryo were sep-
arated by SDS-PAGE and transferred onto nitrocellulose.
After blocking, the membrane was incubated with α-myc
(9E10) or α-CIRP antibody (kindly provided by Ken Mat-
sumoto) and peroxidase-coupled secondary antibody.
Proteins were visualized using ECL-Plus Western Blotting
Detection System (Amersham). As loading control, blots
were incubated with α-Gemin antiserum kindly provided
by U. Fischer, or a parallel Gel was stained with Coomas-
sie brillant blue.
Marker gene analysis
For marker gene analysis by RT-PCR, total RNA was
extracted from whole embryos or animal caps, reverse
transcribed using random hexamer primers and MMLV
reverse transcriptase. For amplification the following
primers were used. Histone 4: 5'-cgggataacattcagggtatcact-
3' and 5'-atccatggcggtaactgtcttctt-3'; XCIRP: 5'-gctgatcag-
gcggggccacc-3' and 5'-gcacccaggctctgtcctgc-3'; XCIRP2: 5'-
ccattcaggctgatcagg-3' and 5'-ctggagagagacgaacac-3'; XAG:
5'-gagttgcttctctggca-3' and 5'-ctgactgtccgatcagac-3'; XANF:
5'-actgacctacaagagagaa-3' and 5'-agtgcatcattgttccacag-3';
ODC: 5'-tggcagcagtacagacagca-3' and 5'-gatgggctggatcg-
tatcct-3'; XTcf-1: 5'-ctcggctcacatgga agatg-3' and 5'-cagatc-
gacaggaaggtg tc-3'; XLef-1: 5'-ggagacctcgcagatatcaa-3' and
5'-ccagccc aatggtggtgtcat-3'; XTcf-3: 5'-catggcagcatgctc-
gactc-3' and 5'-ctggtcactagagaaagggg-3'; XTcf-4: 5'-
ctcacgccgctcattacctacagcaac-3' and 5'-catgtacagcat-
gaacgcgtttagggg-3'; HMGN1: 5'-ggct cctgcttctgatggag-3'
and 5'-ccagtatcaatctctgcctg-3'; HMGN2: 5'-ggggacacaaagt-
gaagc-3' and 5'-cacagtcgaagtaccgcc-3' and HMGX: 5'-cgtc-
cccagataaagagcgag-3' and 5'-gctgcactcgagttcac attc-3'.
NCAM: 5'-ggaatcaagcggtacaga-3' and 5'-cacagttccac-
caaatgc-3'. The XTcf-4 isoforms were determined by
digesting the amplicons with RsaI and XbaI as previously
described [27].
mRNA/total RNA ratio
For analyzing the mRNA/total RNA ratio, 1 μg RNA of
stage 18 embryos was reverse transcribed with MMLV
reverse transcriptase and random hexamer primers (total
RNA) or oligo-dT primers (mRNA) in the presence of 5
μCi [32P]-α-dCTP (3000 Ci/mmol). Radioactive tran-
scripts were separated from unincorporated [32P]-α-dCTP
nucleotides by denaturating polyacrylamide gel electro-
phoresis. Quantity of transcripts was determined via
intensity of radioactive signals (Canberra Packard) and
normalized to total radioactivity.
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Additional File 2
Expression of XCIRP during early embryogenesis. (A) Spatial expres-
sion of XCIRP during early development as revealed by in situ hybridiza-
tion. The arrows indicate high expression of XCIRP in neural tissue. 
Arrowheads point to the expression in the branchial arches. The red arrow 
indicates staining of the pronephros. The open reading frame of XCIRP 
was amplified using the following primers: XCIRPstart: 5'-tcagaattcaat-
gtctgacgaaggaaaact-3' and XCIRPstop 5'-cttctcgagttactcgtgtgtagcatagctg-
3' and sub-cloned into pGEMT for creating labeled antisense RNA. (B) 
Temporal expression of XCIRP and XCIRP2 as revealed by RT-PCR. H4 
indicates the amplification of the house keeping gene histone 4, -RT the 
amplification of H4 in samples, which have not been reverse transcribed. 
The following primer pairs were used: histone 4: 5'-cgggataacattcagggtat-
cact-3' and 5'-atccatggcggtaa ctgtcttctt-3'; XCIRP: 5'-gctgatcaggcg-
gggccacc-3' and 5'-gcacccaggctctgtcctgc-3'; XCIRP2: 5'-
ccattcaggctgatcagg-3' and 5'-ctggagagagacgaacac-3'.
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Additional File 3
Depletion of XTcf-3 has minor effects on the expression of HMG-box 
genes. Depletion of XTcf-3 by injection of two picomoles morpholino 
(Tcf3Mo): 5'-cgctgttgagctgaggcatgatgag-3' (directed against BC077764) 
into one blastomere of 2-cell stage embryos (the injected side is indicated 
by an asterisk) has only minor effects on the expression of HMGN1, 
HMGN2 and HMGX. While HMGN2 and HMGX are laterally 
expanded (arrow), HMGN1 remains unchanged. Probes for in situ 
hybridization are as described: HMGN1 and HMGN2 [1], HMGX [2].
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-8-77-S3.pdf]
Additional File 4
Depletion of XTcf-3 and XCIRP results in a lateral shift of the neur-
oectodermal border. (A) Lateral expansion (arrows) of Meis3, (B) lat-
eral shift (arrows) of eya1 expression following unilateral injection of two 
picomoles XTcf-3 morpholino (Tcf3Mo), XTcf-3 morpholino together with 
1000 pg XTcf-3 mRNA (Tcf3Mo + XTcf-3) or two picomoles XCIRP-mor-
pholino (CIRP-Mo: 5'-agtacagactgcttccttttgaga-3'). The asterisks mark 
the injected side. The quantification gives the percentage of embryos show-
ing lateral expansion of Meis3 (A) or shift of eya1 (B). N gives the 
number of analyzed embryos. Probes for in situ hybridization are as 
described [3].
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